MXPA05007683A - Dispersion de cristales o granulos de sustancias activas con sabor enmascarado, capsulas suaves masticables rellenas con la dispersion, y proceso para la preparacion de los mismos. - Google Patents

Dispersion de cristales o granulos de sustancias activas con sabor enmascarado, capsulas suaves masticables rellenas con la dispersion, y proceso para la preparacion de los mismos.

Info

Publication number
MXPA05007683A
MXPA05007683A MXPA05007683A MXPA05007683A MXPA05007683A MX PA05007683 A MXPA05007683 A MX PA05007683A MX PA05007683 A MXPA05007683 A MX PA05007683A MX PA05007683 A MXPA05007683 A MX PA05007683A MX PA05007683 A MXPA05007683 A MX PA05007683A
Authority
MX
Mexico
Prior art keywords
dispersion
granules
crystals
capsules filled
active substances
Prior art date
Application number
MXPA05007683A
Other languages
English (en)
Inventor
Madeleine Bohn Marie
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of MXPA05007683A publication Critical patent/MXPA05007683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La presente invencion se refiere a una dispersion de cristales o granulos de la sustancia activa en un vehiculo lipofilico, los cristales o granulos son recubiertos por un recubrimiento para fines de enmascaramiento del sabor. La invencion tambien se refiere a las formas de dosis unitaria y preferentemente a las capsulas de gelatina suave masticables o de disolucion rapida rellenas con la dispersion, asi como al proceso para la fabricacion de las mismas.
MXPA05007683A 2003-01-24 2004-01-21 Dispersion de cristales o granulos de sustancias activas con sabor enmascarado, capsulas suaves masticables rellenas con la dispersion, y proceso para la preparacion de los mismos. MXPA05007683A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300824A FR2850275B1 (fr) 2003-01-24 2003-01-24 Capsules molles a macher contenant une substance active a gout masque
PCT/US2004/001463 WO2004066925A2 (en) 2003-01-24 2004-01-21 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same

Publications (1)

Publication Number Publication Date
MXPA05007683A true MXPA05007683A (es) 2005-09-30

Family

ID=32669215

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007683A MXPA05007683A (es) 2003-01-24 2004-01-21 Dispersion de cristales o granulos de sustancias activas con sabor enmascarado, capsulas suaves masticables rellenas con la dispersion, y proceso para la preparacion de los mismos.

Country Status (19)

Country Link
EP (1) EP1592402B1 (es)
JP (1) JP5371187B2 (es)
CN (2) CN1741787A (es)
AR (1) AR042902A1 (es)
AU (1) AU2004207498B2 (es)
BR (1) BRPI0406913B8 (es)
CA (1) CA2512988C (es)
DK (1) DK1592402T3 (es)
ES (1) ES2415660T3 (es)
FR (1) FR2850275B1 (es)
HK (1) HK1082659A1 (es)
MX (1) MXPA05007683A (es)
NO (1) NO339528B1 (es)
NZ (1) NZ541753A (es)
PT (1) PT1592402E (es)
RU (1) RU2362546C2 (es)
SI (1) SI1592402T1 (es)
UA (1) UA84140C2 (es)
WO (1) WO2004066925A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013944A1 (en) * 2003-08-11 2005-02-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
CA2691995C (en) * 2007-07-19 2016-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
CA2706272C (en) * 2010-06-03 2020-05-05 Accucaps Industries Limited Multi phase soft gel capsules, apparatus and method thereof
CA2706270C (en) * 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
AU2012214939B2 (en) * 2011-02-11 2016-11-17 Ctc Bio, Inc. Sildenafil-free base-containing film preparation and method for producing same
CA3023121A1 (en) * 2011-04-11 2012-10-18 Vitux Group As Oral pharmaceutical dispersion compositions
EP2699267A4 (en) * 2011-04-18 2014-11-12 Lipidor Ab LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE
CN102241782B (zh) * 2011-05-18 2013-01-30 清华大学 一种淀粉乙酸酯的制备方法及其在去除水中硝酸盐的应用
CN102813275B (zh) 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant
ES2972665T3 (es) * 2015-03-26 2024-06-13 Patheon Softgels Inc Cápsulas liquisoft
SI3429559T1 (sl) 2016-03-15 2022-11-30 Acer Therapeutics Inc. Okusni sestavki, ki vključujejo natrijev fenilbutirat, in njihove uporabe
JP6942342B2 (ja) * 2016-11-02 2021-09-29 富士カプセル株式会社 ソフトカプセル皮膜
JP2018121699A (ja) * 2017-01-30 2018-08-09 株式会社アクレス クリルオイルを充填したカプセル剤
CN107373744B (zh) * 2017-07-13 2018-11-09 云南中烟工业有限责任公司 一种维生素c微胶囊的制备方法及其在卷烟中的应用
CN108524464A (zh) * 2018-05-17 2018-09-14 安士制药（中山）有限公司 一种西甲硅油软胶囊的制备方法
AU2020223894A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising Ibuprofen
WO2020169991A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
EP3927314B1 (en) * 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623557D0 (en) 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
CH677606A5 (es) 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US4975465A (en) 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
CA2063141C (en) 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5262179A (en) 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
ATE121619T1 (de) 1990-04-11 1995-05-15 Upjohn Co Verfahren zum geschmacksabdecken von ibuprofen.
JP3157233B2 (ja) * 1991-11-22 2001-04-16 エーザイ株式会社 水溶性薬物を含有した軟カプセル剤
JP3136310B2 (ja) * 1992-02-26 2001-02-19 東洋カプセル株式会社 咀嚼服用に適した担体
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
DE69313865T2 (de) * 1992-10-16 1998-02-12 Glaxo Group Ltd Geschmacksmaskierende zusammensetzungen von ranitidin
GB9313329D0 (en) * 1993-06-28 1993-08-11 Scherer Ltd R P Softgel capsule shell compositions
US5466865A (en) 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
EP1163901B1 (en) * 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20030096791A1 (en) * 2001-05-31 2003-05-22 Cima Labs Inc. Taste masking of highly water-soluble drugs

Also Published As

Publication number Publication date
EP1592402A2 (en) 2005-11-09
FR2850275A1 (fr) 2004-07-30
NO339528B1 (no) 2016-12-27
NO20053681L (no) 2005-08-23
FR2850275B1 (fr) 2005-04-08
AU2004207498A1 (en) 2004-08-12
CA2512988C (en) 2015-11-10
HK1082659A1 (en) 2006-06-16
WO2004066925A3 (en) 2004-10-28
EP1592402A4 (en) 2009-01-14
BRPI0406913B1 (pt) 2016-03-01
ES2415660T3 (es) 2013-07-26
SI1592402T1 (sl) 2013-08-30
WO2004066925B1 (en) 2004-12-09
RU2362546C2 (ru) 2009-07-27
JP2007525413A (ja) 2007-09-06
DK1592402T3 (da) 2013-06-24
CN1741787A (zh) 2006-03-01
WO2004066925A2 (en) 2004-08-12
NZ541753A (en) 2008-12-24
AU2004207498B2 (en) 2008-10-30
UA84140C2 (ru) 2008-09-25
RU2005126729A (ru) 2006-03-10
AR042902A1 (es) 2005-07-06
BRPI0406913A (pt) 2006-01-03
CA2512988A1 (en) 2004-08-12
CN103169655A (zh) 2013-06-26
JP5371187B2 (ja) 2013-12-18
EP1592402B1 (en) 2013-03-20
PT1592402E (pt) 2013-06-25
BRPI0406913B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
MXPA05007683A (es) Dispersion de cristales o granulos de sustancias activas con sabor enmascarado, capsulas suaves masticables rellenas con la dispersion, y proceso para la preparacion de los mismos.
NO333265B3 (no) Substituerte dihydrokinazoliner, fremgangsmåte for fremstilling derav, anvendelse av en slik forbindelse samt medikament inneholdende denne.
IL183871A0 (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
WO2007143652A3 (en) Chewable soft gelatin capsules
EA200501586A1 (ru) Фармацевтические продукты
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
NO2012017I1 (no) Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen.
HK1090042A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the of the same as medicaments, and medicament containing such compounds
HK1103393A1 (en) Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
PL393385A1 (pl) Sposób modyfikacji i rekrystalizacji pokroju kryształów substancji leczniczej, kryształy mykofenolanu sodu i ich zastosowanie oraz kompozycja farmaceutyczna
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
ZA200705119B (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
WO2006074185A3 (en) Taste masking system for non-plasticizing drugs
IL174761A0 (en) Method for producing acyl urea derivatives salts of said acyl urea derivatives, and the use thereof as pesticides
WO2008012086A3 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
WO2009120844A3 (en) Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
WO2004041166A3 (en) Dosage forms containing stabilized choline and method for preparing same
GR1004331B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
TH74314A (th) สารผสมทางเภสัชกรรม
TH69665A (th) อนุพันธ์เฮเทโรไซคลิกฟลูออโรไกลโคไซด์แบบใหม่ สารรักษาโรคซึ่งมีสารประกอบเหล่านี้ และการใช้สารนั้น
WO2004108089A3 (en) A micro granulate formulation for oral administration in aqueous suspension

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status